Jihong Liu Selected Research

Ovarian Epithelial Carcinoma

6/2024	Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial.
1/2023	A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.
1/2021	The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.
1/2021	Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
9/2020	Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.
1/2015	GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer.
1/2012	Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jihong Liu Research Topics

Disease

75	Neoplasms (Cancer) 05/2024 - 04/2003
36	Ovarian Neoplasms (Ovarian Cancer) 06/2024 - 07/2009
30	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 03/2010
28	Erectile Dysfunction 01/2024 - 01/2016
17	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024 - 09/2004
17	Fibrosis (Cirrhosis) 01/2024 - 01/2016
12	Carcinoma (Carcinomatosis) 06/2024 - 03/2007
11	Diabetes Mellitus 01/2024 - 08/2013
7	Ovarian Epithelial Carcinoma 06/2024 - 01/2012
7	Inflammation (Inflammations) 01/2024 - 01/2020
7	COVID-19 01/2024 - 01/2020
7	Infections 01/2023 - 04/2011
7	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2011
7	Body Weight (Weight, Body) 01/2023 - 01/2004
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021 - 01/2016
7	Urolithiasis 01/2019 - 04/2003
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2014
6	Disease Progression 12/2022 - 01/2020
6	Ischemia 01/2022 - 04/2011
6	Calculi (Calculus) 01/2017 - 04/2003
5	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 04/2013
5	Reperfusion Injury 01/2023 - 09/2019
5	Chemical and Drug Induced Liver Injury 12/2022 - 01/2021
5	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 07/2013
5	Obesity 12/2020 - 01/2015
4	Idiopathic Hypogonadotropic Hypogonadism 07/2024 - 10/2020
4	Wounds and Injuries (Trauma) 01/2024 - 01/2020
4	Hypertension (High Blood Pressure) 10/2023 - 07/2014
4	Pain (Aches) 06/2023 - 07/2016
4	Premature Birth (Birth, Premature) 12/2022 - 02/2011
4	Kidney Calculi (Kidney Stone) 01/2022 - 05/2012
4	Prostatitis 01/2022 - 04/2004
4	Asthma (Bronchial Asthma) 11/2017 - 07/2012
4	Urinary Calculi (Urinary Calculus) 01/2017 - 12/2011
4	Hydronephrosis 12/2011 - 10/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 12/2021
3	Hemorrhage 01/2024 - 08/2020
3	Infertility (Sterility) 08/2023 - 01/2005
3	Pelvic Pain 01/2022 - 04/2004
3	Lymphatic Metastasis 01/2021 - 11/2005
3	Ischemic Stroke 10/2020 - 08/2002
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2015
3	Atrophy 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2011
24	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2010
17	PlatinumIBA 06/2024 - 08/2007
11	Streptozocin (Streptozotocin)FDA Link 01/2024 - 01/2016
11	Androgen Receptors (Androgen Receptor)IBA 07/2022 - 09/2011
10	AndrogensIBA 01/2021 - 09/2011
8	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2024 - 10/2017
8	RNA (Ribonucleic Acid)IBA 10/2022 - 08/2013
8	Calcium OxalateIBA 01/2022 - 04/2003
7	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 09/2014
6	Messenger RNA (mRNA)IBA 11/2020 - 04/2011
5	niraparibIBA 06/2024 - 01/2020
5	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 02/2011
5	Apomorphine FDA Link 01/2024 - 01/2019
5	VaccinesIBA 11/2021 - 12/2019
4	olaparibIBA 05/2024 - 01/2021
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2024 - 02/2020
4	Therapeutic UsesIBA 01/2023 - 08/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2011
4	CalciumIBA 01/2023 - 10/2008
4	MicroRNAs (MicroRNA)IBA 01/2023 - 11/2016
4	Peroxynitrous Acid (Peroxynitrite)IBA 12/2022 - 12/2019
4	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2011
4	BerberineIBA 01/2022 - 11/2019
4	Fluorescent Dyes (Fluorescent Probes)IBA 11/2021 - 01/2021
4	Testosterone (Sustanon)FDA Link 10/2021 - 01/2016
4	AntigensIBA 01/2021 - 09/2012
3	CreatinineIBA 02/2024 - 01/2021
3	ParaffinIBA 01/2023 - 11/2014
3	Phosphotransferases (Kinase)IBA 01/2023 - 06/2014
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 10/2013
3	Phosphodiesterase 5 InhibitorsIBA 01/2023 - 09/2022
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 01/2017
3	Hemoglobins (Hemoglobin)IBA 10/2022 - 01/2017
3	Hormones (Hormone)IBA 01/2022 - 01/2020
3	CollagenIBA 01/2022 - 01/2019
3	fluzoparibIBA 01/2022 - 06/2020
3	Superoxides (Superoxide)IBA 01/2021 - 09/2019
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2020
3	UbiquitinIBA 01/2021 - 05/2016
3	AntioxidantsIBA 10/2020 - 01/2017
3	Angiogenesis InhibitorsIBA 12/2019 - 07/2013

Therapy/Procedure

51	Therapeutics 06/2024 - 07/2009
22	Drug Therapy (Chemotherapy) 06/2024 - 07/2009
12	Castration 01/2021 - 06/2014
11	Neoadjuvant Therapy 01/2023 - 02/2011
9	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 02/2011
6	Prenatal Care (Care, Prenatal) 11/2023 - 10/2011
6	Nephrectomy 10/2013 - 04/2003
5	Immunotherapy 12/2023 - 01/2021
5	Adjuvant Chemotherapy 03/2017 - 04/2013
4	Transplantation 01/2023 - 04/2011
4	Hysterectomy 01/2023 - 02/2011
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 04/2017
3	Intraperitoneal Injections 01/2024 - 01/2004
3	Cytoreduction Surgical Procedures 01/2022 - 01/2015
3	Lasers (Laser) 03/2018 - 04/2011